Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: Results of a population-based cohort study

British Journal of Haematology

Volumn 156, Issue 5, 2012, Pages 667-671

  Van Schouwenburg, Inge M ^a   Mahmoodi, Bakhtawar K ^a   Veeger, Nic J G M ^a   Kluin Nelemans, Hanneke C ^a   Gansevoort, Ron T ^a   Meijer, Karina ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Albumin; Albuminuria; Microalbuminuria; Recurrence; Recurrent venous thromboembolism; Venous thromboembolism

Indexed keywords

ALBUMIN; ANTIVITAMIN K; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; COHORT ANALYSIS; DEATH CERTIFICATE; FEMALE; GENDER; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NETHERLANDS; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RECURRENCE RISK; REGISTER; TREATMENT DURATION; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ALBUMINURIA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RECURRENCE; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

EID: 84857032784     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.09018.x     Document Type: Article

References (18)

1. Agewall, S., Lindstedt, G. & Fagerberg, B. (2001) Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men. Atherosclerosis, 157, 197-202.
2. Bangstad, H.J., Try, K., Dahl-Jorgensen, K. & Hanssen, K.F. (1991) New semiquantitative dipstick test for microalbuminuria. Diabetes Care, 14, 1094-1097.
3. Brantsma, A.H., Bakker, S.J., de Zeeuw, D., de Jong, P.E., Gansevoort, R.T. & PREVEND Study Group (2008) Extended prognostic value of urinary albumin excretion for cardiovascular events. Journal of the American Society of Nephrology, 19, 1785-1791.
4. Christiansen, S.C., Cannegieter, S.C., Koster, T., Vandenbroucke, J.P. & Rosendaal, F.R. (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. The Journal of the American Medical Association, 293, 2352-2361.
5. Cushman, M., Tsai, A.W., White, R.H., Heckbert, S.R., Rosamond, W.D., Enright, P. & Folsom, A.R. (2004) Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. The American Journal of Medicine, 117, 19-25.
6. Dahabreh, I.J. & Kent, D.M. (2011) Index event bias as an explanation for the paradoxes of recurrence risk research. The Journal of the American Medical Association, 305, 822-823.
7. Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D., Tait, R.C. & Iorio, A. (2011) Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. British Medical Journal, 342, d813.
8. Gruden, G., Cavallo-Perin, P., Bazzan, M., Stella, S., Vuolo, A. & Pagano, G. (1994) PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes, 43, 426-429.
9. Hansson, P.O., Welin, L., Tibblin, G. & Eriksson, H. (1997) Deep vein thrombosis and pulmonary embolism in the general population. 'The study of men born in 1913'. Archives of Internal Medicine, 157, 1665-1670.
10. Hansson, P.O., Sorbo, J. & Eriksson, H. (2000) Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Archives of Internal Medicine, 160, 769-774.
11. Hillege, H.L., Janssen, W.M., Bak, A.A., Diercks, G.F., Grobbee, D.E., Crijns, H.J., Van Gilst, W.H., De Zeeuw, D. & De Jong, P.E. (2001) Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. Journal of Internal Medicine, 249, 519-526.
12. Kario, K., Matsuo, T., Kobayashi, H., Matsuo, M., Sakata, T., Miyata, T. & Shimada, K. (1996) Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 455-461.
13. Levine, M.N., Raskob, G., Landefeld, S. & Kearon, C. (1998) Hemorrhagic complications of anticoagulant treatment. Chest, 114, 511S-523S.
14. Linkins, L.A., Choi, P.T. & Douketis, J.D. (2003) Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Annals of Internal Medicine, 139, 893-900.
15. Mahmoodi, B.K., Gansevoort, R.T., Veeger, N.J., Matthews, A.G., Navis, G., Hillege, H.L. & van der Meer, J. (2009) Microalbuminuria and risk of venous thromboembolism. The Journal of the American Medical Association, 301, 1790-1797.
16. Meijer, K. & Schulman, S. (2009) The absence of 'minor' risk factors for recurrent venous thromboembolism: a systematic review of negative predictive values and negative likelihood ratios. Journal of Thrombosis and Haemostasis, 7, 1619-1628.
17. Naess, I.A., Christiansen, S.C., Romundstad, P., Cannegieter, S.C., Rosendaal, F.R. & Hammerstrom, J. (2007) Incidence and mortality of venous thrombosis: a population-based study. Journal of Thrombosis and Haemostasis, 5, 692-699.
18. Palareti, G., Legnani, C., Cosmi, B., Valdre, L., Lunghi, B., Bernardi, F. & Coccheri, S. (2003) Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation, 108, 313-318.